Floatz logo

ha35

Myofascial Pain Syndrome

Nakhia Impex LLCN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Myofascial Pain Syndrome cohort.

Asset / SponsorPhaseRating
Granisetron
Karolinska Institutet
Phase 4BB
Imc-1
Innovative Med Concepts, LLC
Phase 2B
Capsaicin
Stamford Hospital
Phase 2CCC
Solvazinc
Cairo University
Early Phase 1C
BICARBONATE ION
Cairo University
N/AD

View all 12 →

Same molecule, other indications

ha35 is also rated in:

chronic ulcer of skinDormant
D
Indicative ·
30 / 100
View asset →
cancer-related conditionDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →